Pemetrexed plus Platinum Chemotherapy with or Without Immuno Responses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions Therapy in Non-Squamous NSCLC: Descriptive Safety Analysis

被引：0
|
作者：
Li, X.
Li, J.
机构：
[1] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Med Oncol, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
bevacizumab; Cisplatin; malignant pleural effusion;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-041
引用
收藏
页码：S2084 / S2084
页数：1
相关论文
共 50 条
  • [41] Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study
    Santoro, Armando
    Hillerdal, Gunnar N.
    Hoeffkenc, Gert
    Favaretto, Adolfo
    Carrion, Ramon Perez
    Visseren-Grul, Carla
    Ameryckx, Sophie
    Helsberg, Karin
    Soldatenkova, Victoria
    Bourayou, Nawel
    Sorensen, Jens B.
    LUNG CANCER, 2014, 86 (01) : 47 - 53
  • [42] An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer
    Kaira, Kyoichi
    Imai, Hisao
    Souma, Ryousuke
    Sakurai, Reiko
    Miura, Yosuke
    Sunaga, Noriaki
    Kasahara, Norimitsu
    Tsukagoshi, Yusuke
    Koga, Yasuhiko
    Kitahara, Shinsuke
    Kotake, Mie
    Minato, Koichi
    Naruse, Ichiro
    Fukushima, Yasutsugu
    Hisada, Takeshi
    Ishizuka, Tamotsu
    ANTICANCER RESEARCH, 2019, 39 (05) : 2483 - 2491
  • [43] Bevacizumab and weekly paclitaxel for non-squamous non small cell lung cancer patients: A retrospective study
    Habib, Stefanie
    Delourme, Julie
    Dhalluin, Xavier
    Petyt, Gregory
    Tacelli, Nunzia
    Scherpereel, Arnaud
    Lafitte, Jean-Jacques
    Cortot, Alexis B.
    LUNG CANCER, 2013, 80 (02) : 197 - 202
  • [44] Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Kawano, Yuko
    Sakatani, Toshio
    Tanimoto, Azusa
    Nishizawa, Hironari
    Horiike, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2014, 34 (09) : 5153 - 5158
  • [45] Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression
    Felipe Cardona, Andres
    Rojas, Leonardo
    Wills, Beatriz
    Arrieta, Oscar
    Carranza, Hernan
    Vargas, Carlos
    Otero, Jorge
    Cuello, Mauricio
    Corrales, Luis
    Martin, Claudio
    Ortiz, Carlos
    Franco, Sandra
    Rosell, Rafael
    PLOS ONE, 2016, 11 (05):
  • [46] A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016)
    Satoru Miura
    Makoto Maemondo
    Akira Iwashima
    Toshiyuki Harada
    Shunichi Sugawara
    Kunihiko Kobayashi
    Akira Inoue
    Taku Nakagawa
    Yuichi Takiguchi
    Hiroshi Watanabe
    Takashi Ishida
    Masaki Terada
    Hiroshi Kagamu
    Akihiko Gemma
    Hirohisa Yoshizawa
    Investigational New Drugs, 2017, 35 : 227 - 234
  • [47] A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016)
    Miura, Satoru
    Maemondo, Makoto
    Iwashima, Akira
    Harada, Toshiyuki
    Sugawara, Shunichi
    Kobayashi, Kunihiko
    Inoue, Akira
    Nakagawa, Taku
    Takiguchi, Yuichi
    Watanabe, Hiroshi
    Ishida, Takashi
    Terada, Masaki
    Kagamu, Hiroshi
    Gemma, Akihiko
    Yoshizawa, Hirohisa
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 227 - 234
  • [48] Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
    Bilger, Geoffroy
    Toffart, Anne-Claire
    Darrason, Marie
    Duruisseaux, Michael
    Ulmer, Lucie
    Wang, Pascal
    Leprieur, Etienne Giroux
    Girard, Nicolas
    Massiani, Marie Ange
    Bore, Paul
    Descourt, Renaud
    Pinsolle, Julian
    Valery, Solene
    Monnet, Isabelle
    Swalduz, Aurelie
    Tissot, Claire
    Fournel, Pierre
    Baranzelli, Anne
    Cortot, Alexis B.
    Decroisette, Chantal
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [49] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
  • [50] Gefitinib Plus Bevacizumab vs. Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Mori, Masahide
    Ichiki, Masao
    Sukoh, Noriaki
    Kada, Akiko
    Saito, Akiko M.
    Ichinose, Yukito
    IN VIVO, 2019, 33 (02): : 477 - 482
12345